Cancer

Papers
(The H4-Index of Cancer is 44. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Issue Information389
Sharp rise in esophageal cancer and Barrett esophagus seen in middle‐aged people246
Issue Information196
Stopping immunotherapy after 2 years is practical in patients with advanced non–small cell lung cancer192
MRI is more accurate than a PSMA PET/CT scan for prostate cancer diagnosis151
Updated American Cancer Society lung cancer screening guidelines147
Issue Information124
109
Cutaneous β‐HPV may predict cutaneous squamous cell carcinoma108
Issue Information88
New standard of care for multiple myeloma?81
80
Erratum to “Landscape of DNA damage response gene alterations in breast cancer: A comprehensive investigation”76
The role of relative advantage for development of sequencing‐based diagnostics for pediatric cancer in low‐ and middle‐income countries74
New test for detecting cervical adenocarcinoma70
62
Accelerated approval of multiple myeloma therapies62
Cancer‐related impairments and functional limitations among long‐term cancer survivors: Gaps and opportunities for clinical practice60
Active surveillance after neoadjuvant chemoradiotherapy for esophageal cancer57
Occurrence of breast‐cancer–related lymphedema after reverse lymphatic mapping and selective axillary dissection versus standard surgical treatment of axilla: A two‐arm randomized clinical trial57
Significance of HIV status in cervical cancer patients receiving curative chemoradiation therapy, definitive radiation alone, or palliative radiation in Botswana55
Let's ask the patient: Self‐reported quality‐of‐life measures help to predict kidney cancer mortality54
54
A single‐arm, multicenter, open‐label phase 2 trial of surufatinib in patients with unresectable or metastatic biliary tract cancer54
Active Living After Cancer: Adaptation and evaluation of a community‐based physical activity program for minority and medically underserved breast cancer survivors53
Association of the social disorganization index with time to first septic shock event in children with acute myeloid leukemia52
Evaluation of headache in patients with cancer51
Impact of African ancestry on the relationship between body mass index and survival in an early‐stage breast cancer trial (ECOG‐ACRIN E5103)50
What are the most effective exercise, physical activity and dietary interventions to improve body composition in women diagnosed with or at high‐risk of breast cancer? A systematic review and network 50
Reply to “Empathic communication: The premise of inclusive care for historically excluded populations”50
Impact of TAILORx on chemotherapy prescribing and 21‐gene recurrence score–guided treatment costs in a population‐based cohort of patients with breast cancer50
The economics of advanced and unresectable hepatocellular carcinoma48
Understanding risk factors for cancer: What's new and how can it help reduce the cancer burden?47
Patterns of failure in pediatric medulloblastoma and implications for hippocampal sparing47
Potential of circulating tumor DNA to refine immunotherapy46
What enhanced recovery means for patients with cancer undergoing surgery46
Epistemic equity in oncology: Opportunities to leverage patient‐centric implementation in clinical trial design46
Top advances of the year: Cervical cancer46
Detection of recurrent colorectal cancer with high specificity using a reporting threshold for circulating tumor DNA methylated in BCAT1 and IKZF145
Dietary supplement use among adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort Study45
45
Can we avoid thoracic radiotherapy in young females with Hodgkin lymphoma?45
Aspirin but not statins is inversely related to gastric cancer with a duration–risk effect: Results from the Stomach Cancer Pooling Project Consortium45
Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data44
0.072366952896118